Clene Inc. (CLNN): Total Assets
$18.13M
As of 2025-12-31
$23.04M
As of 2026-06-30
-25.9%
3-year compound annual growth
-23.3%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.13M | -33.7% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $27.34M | -47.8% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $52.34M | +17.6% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $44.49M | -29.4% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $63.06M | -7.6% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $68.24M | +358.7% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $14.88M | n/a | 2021-03-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $18.13M | -33.7% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $17.74M | -49.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $21.06M | +179.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
Compare CLNN, LSTA, RGBP, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗